Inventor · disambiguated record
Alberto Ortega Muñoz
Also filed as: ORTEGA MUENOZ ALBERTO · ORTEGA MUNOZ ALBERTO · ORTEGA MUÑOZ ALBERTO
17 granted patents·5 pending applications·164 citations·filing 2007–2022
94Inventor score
Files withORYZON GENOMICS SA15ORTEGA MUÑOZ ALBERTO3ALMIRALL LAB1FYFE MATTHEW COLIN THOR1GUIBOURT NATHALIE1
Top patents by PatentIndex Score
22 records- 0194US8722743B2Lysine specific demethylase-1 inhibitors and their useORTEGA MUNOZ ALBERTO·Filed 2011·Granted May 13, 2014·28 cites·69 claims
- 0289US9670136B2(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2016·Granted Jun 6, 2017·8 cites·26 claims
- 0389US9181198B2Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical useORTEGA MUÑOZ ALBERTO·Filed 2011·Granted Nov 10, 2015·17 cites·63 claims
- 0489US9006449B2Cyclopropylamine derivatives useful as LSD1 inhibitorsFYFE MATTHEW COLIN THOR·Filed 2011·Granted Apr 14, 2015·19 cites·26 claims
- 0589US8946296B2Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their useORTEGA MUÑOZ ALBERTO·Filed 2010·Granted Feb 3, 2015·17 cites·33 claims
- 0689US8859555B2Lysine Specific Demethylase-1 inhibitors and their useORTEGA MUÑOZ ALBERTO·Filed 2010·Granted Oct 14, 2014·18 cites·23 claims
- 0787US9708309B2Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical useORYZON GENOMICS SA·Filed 2015·Granted Jul 18, 2017·7 cites·12 claims
- 0887US8993808B2Phenylcyclopropylamine derivatives and their medical useGUIBOURT NATHALIE·Filed 2010·Granted Mar 31, 2015·18 cites·30 claims
- 0986US9676701B2Cyclopropylamine derivatives useful as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2015·Granted Jun 13, 2017·7 cites·20 claims
- 1086US9487512B2(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2012·Granted Nov 8, 2016·8 cites·60 claims
- 1186US9469597B2(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2012·Granted Oct 18, 2016·8 cites·14 claims
- 1284US9944601B2(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2016·Granted Apr 17, 2018·4 cites·19 claims
- 1378US11034991B2Methods to determine KDM1A target engagement and chemoprobes useful thereforORYZON GENOMICS SA·Filed 2017·Granted Jun 15, 2021·2 cites·12 claims
- 1476US10329256B2(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2018·Granted Jun 25, 2019·1 cites·19 claims
- 1575US10214477B2(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2017·Granted Feb 26, 2019·1 cites·8 claims
- 1674US10233178B2Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical useORYZON GENOMICS SA·Filed 2017·Granted Mar 19, 2019·1 cites·5 claims
- 1770US12195783B2Methods to determine KDM1A target engagement and chemoprobes useful thereforORYZON GENOMICS SA·Filed 2021·Granted Jan 14, 2025·0 cites·13 claims
- 1859US2023026909A11,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitorsORYZON GENOMICS SA·Filed 2022·Application pending·0 cites
- 1950US2010168161A1Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptorALMIRALL LAB·Filed 2007·Application pending·0 cites
- 2044US2020339569A11,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitorsORYZON GENOMICS SA·Filed 2018·Application pending·0 cites
- 2141US2016000768A1Cyclopropylamine inhibitors of oxidasesORYZON GENOMICS SA·Filed 2015·Application pending·0 cites
- 2238US2016045456A1Phenylcyclopropylamine derivatives and their medical useORYZON GENOMICS SA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alberto Ortega Muñoz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →